Literature DB >> 479902

Relationship between presence of vasoconstrictor activity in cerebrospinal fluid and time after subarachnoid haemorrhage from rupture of cerebral arterial aneurysms.

T M Hunt, G H Du Boulay, W P Blaso, D M Forster, D J Boullin.   

Abstract

The relationship between clinical condition and vasoconstrictor factors in cerebrospinal fluid was studied in 19 patients for up to six weeks after subarachnoid haemorrhage. Vasoconstrictor activity was assayed biologically. Sixteen of 19 patients improved as vasoconstrictor activity declined; this pattern was not significantly influenced by surgery. Serial angiography was performed on three patients and a qualitative relationship was shown between arterial dilatation, clinical improvement, and reduced pharmacological activity.

Entities:  

Mesh:

Year:  1979        PMID: 479902      PMCID: PMC490276          DOI: 10.1136/jnnp.42.7.625

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  28 in total

1.  DEMONSTRATION OF SUBSTANCES CAPABLE OF CONTRACTING SMOOTH MUSCLE IN THE HAEMATOMA FLUID FROM CERTAIN CASES OF RUPTURED CEREBRAL ANEURYSM.

Authors:  M BUCKELL
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-06       Impact factor: 10.154

2.  RUPTURED INTRACRANIAL ANEURYSMS--THE ROLE OF ARTERIAL SPASM.

Authors:  J M ALLCOCK; C G DRAKE
Journal:  J Neurosurg       Date:  1965-01       Impact factor: 5.115

3.  Direct tension recording from smooth muscle of resistance vessels from various organs.

Authors:  D F BOHR; P L GOULET; A C TAQUINI
Journal:  Angiology       Date:  1961-10       Impact factor: 3.619

4.  Cerebrovascular effects of topically applied serotonin in the cat.

Authors:  R B RAYNOR; J G McMURTRY; J L POOL
Journal:  Neurology       Date:  1961-03       Impact factor: 9.910

5.  Aetiology of cerebral arterial spasm following subarachnoid haemorrhage: evidence against a major involvement of 5-hydroxy-tryptamine in the production of acute spasm.

Authors:  D J Boullin; G H Du Boulay; A T Rogers
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

6.  Effects of intracranial dopamine perfusion: behavioural arousal and reversal of cerebral arterial spasm following surgery for clipping of ruptured cerebral aneurysms.

Authors:  D J Boullin; C B Adams; J Mohan; A R Green; T M Hunt; G H du Boulay; A T Rogers
Journal:  Proc R Soc Med       Date:  1977

7.  Time course of vasospasm in man.

Authors:  B Weir; M Grace; J Hansen; C Rothberg
Journal:  J Neurosurg       Date:  1978-02       Impact factor: 5.115

8.  An investigation with serial angiography into the evolution of cerebral arterial spasm following aneurysm surgery.

Authors:  C B Adams; M R Fearnside; S A O'Laoire
Journal:  J Neurosurg       Date:  1978-12       Impact factor: 5.115

9.  Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in man.

Authors:  D J Boullin; S Bunting; W P Blaso; T M Hunt; S Moncada
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

10.  Effects of (+) and (-)-propranolol on the responses of the human isolated basilar artery to cerebrospinal fluid obtained from patients with subarachnoid haemorrhage and cerebral arterial spasm.

Authors:  D J Boullin; J Mohan
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

View more
  2 in total

1.  The calibre of cerebral arteries of the rat studied by carotid angiography: a model system for studying the aetiology of human cerebral arterial constriction after aneurysmal rupture.

Authors:  D J Boullin; V Aitken; G H du Boulay; P Tagari
Journal:  Neuroradiology       Date:  1981       Impact factor: 2.804

2.  The 5-hydroxytryptamine antagonist ketanserin inhibits the vasoconstrictor activity of per-operative CSF, from subarachnoid haemorrhage patients, on isolated tissues.

Authors:  P C Tagari; A H Kaye; P J Teddy; M Schachter; C B Adams; D J Boullin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.